Dual-mode enhancement of metallothionein protein with cell transduction and retention peptide fusion

Kwang Suk Lim, Myoung Hwa Lim, Young Wook Won, Jang Kyoung Kim, Young Cheol Kang, Eun Jeong Park, Ji Won Chae, So Mi Kim, Seong Eon Ryu, Youngmi Kim Pak, Yong Hee Kim

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Protein transduction domains (PTDs), also known as cell-penetrating peptides (CPPs), have been developed as effective systems for delivering bio-active cargos such as proteins, genes and particles. Further improvements on cell-specific targeting, intracellular organelle targeting and intracellular retention are still necessary to enhance the therapeutic effect of PTD fusion proteins. In order to enhance the cell transduction and retention of anti-oxidative metallothionein protein (MT), MT was recombinantly fused with transcriptional activator (Tat) with or without a short peptide (sMTS) derived from mitochondria malate dehydrogenase (mMDH). Cellular uptake and retention time of fusion protein were significantly increased in the H9c2 cell by sMTS. The Tat-sMTS-MT (TMM) fusion protein protected H9c2 cells more effectively against hypoxia, hyperglycemia and combination compared with Tat-MT (TM) by reducing intracellular ROS level. It maintained the normal blood glucose level over an extended period of time in a streptozotocin-induced diabetic mouse model. PTD-sMTS-MT fusion protein has a potential to be used as a therapeutic protein for the treatment or prevention of diabetes and diabetic complications.

Original languageEnglish (US)
Pages (from-to)193-200
Number of pages8
JournalJournal of Controlled Release
Volume171
Issue number2
DOIs
StatePublished - 2013
Externally publishedYes

Keywords

  • Antioxidant agent
  • Diabetic complications
  • Hypoxia
  • Metallothionein fusion protein
  • Protein transduction domain

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Dual-mode enhancement of metallothionein protein with cell transduction and retention peptide fusion'. Together they form a unique fingerprint.

Cite this